Dr. Ing. h.c. F. Porsche stock
P911.DEXETRADr. Ing. h.c. F. Porsche AG, Consumer CyclicalISIN DE000PAG9113WKN PAG911
56Score 56 out of 100, Neutral
Price and trend
80 / 100
Price history
−1.9% in one yearThe chart shows daily closes over 4 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 5.4% above it.
Since June 2026 the 50-day line has been above the 200-day line; the trend has turned up.
Overheated: the price has risen very quickly lately (RSI 73).
The price is 8.1% below its 52-week high. Largest decline in 4 years: 70% (May 2023 to March 2026).
Chart figures for advanced users
- SMA 50$49.28
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$48.33
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)73
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$40.40
- The lowest closing price of the last twelve months.
- Resistance$55.42
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Dr. Ing. h.c. F. Porsche AG belongs to the Auto (Manufacturers) industry (Germany) and, with a market value of $46.43B, is number 7 of 55 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $40.36B (down 9.5% year on year) and earnings of $479.57M (down 88%).
- For fiscal 2026, analysts expect on average revenue of $38.49B (down 4.6%) and adjusted earnings per share of $2.29 (up 327.4%).
Show more
- MEQIRI Score 56 out of 100 (Neutral): rank 391 of 602 in Consumer Cyclical, median 61.
- The P/E is 19 (Auto (Manufacturers) median 19.1, own median of recent years 16.1).
- Our model puts fair value at $58.38, with the price 12% below it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Consistently profitableProfit in all 8 fiscal years from 2018 to 2025.Fundamentals 66
Weaknesses
- Margin fallingOperating margin 4.4%, average of the prior years 16.1% (to 2024).Profitability 42
- Earnings per share fallingDown 33% a year since 2020.Growth 21
Its standout strengths are technical analysis and stability, while profitability and growth hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
The fundamentals are in the middle range.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk low
How well MEQIRI warnsOne of the 30% with the lowest crash risk among stocks ranked 101 to 1,000.
From 2016 to 2025, 9 in 100 such stocks fell 30% or more within a year, against a group average of 15 in 100.
What lowers it
- low growth grade (crashed less often in the backtest)
- price near its 52-week high
Valuation
Valuation signal
Fairly valuedClosing price of 11 Nov 2026, used by the daily score.
In our model the price counts as cheap below $44.91 and expensive above $83.40 (uncertainty medium, based on the price swings of the past year).
The two parts of the fair value come to $65.51 (cash-flow model) and $51.25 (industry comparison), and the gap between them shows how uncertain the estimate is.
Calculated with a cost of equity of 7.1%. At 8.1% the fair value would be $52.19, at 6.1% it would be $67.73.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (19.1).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue fell 9.6% on the twelve months before. Revenue has grown solidly since 2018, at about 5% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 18%, operating 4%, net 1%. Last 12 months: net 6%.
Debt & balance sheet
latest quarterThe balance sheet is solid, with moderate debt and comfortable interest coverage.
Earnings
- Next earnings
- 17 Mar 2027in 125 days
- Last reported
- 27 Oct 2026EPS reported $0.85 (expected $0.48)above expectations
Analyst estimates
Analysts have cut their 2027 earnings estimate by 6.0% since 15 Oct 2026. Falling estimates often precede bad news.
- Earnings per share
- $2.29+5.6%
- Revenue
- $38.49B−0.8%
- Earnings per share
- $1.97−6.0%
- Revenue
- $37.42B−1.4%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook confirmed
Share price after the results: +8.1%Porsche confirms its unchanged full year 2026 guidance of 5.5 to 7.5% operating return on sales and 5.5 to 7.5% net cash flow margin, but flags 2027 as a weaker transitional year with lower volumes.
“We continue to expect a group operating return on sales of 5.5% to 7.5% for the full year.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 27 Oct 2026 (fiscal Q3 2026), read by AI.
What happened at Dr. Ing. h.c. F. Porsche
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
602 rated companies in Consumer Cyclical
- This company
- 56
- Sector median
- 61
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Auto (Manufacturers)
The next larger and next smaller companies by market value
- BYD002594.SZ $112.13B56
- General MotorsGM $75.48B58
- FerrariRACE.MI $73.2B83
- Ford MotorF $48.92B43
- Maruti Suzuki IndiaMARUTI.NS $44.24B62
- Mercedes-Benz GroupMBG.DE $44.12B52
- Honda MotorHMC $43.95B52
- Hyundai Motor005380.KS $41.52B49
ETFs that hold Dr. Ing. h.c. F. Porsche
Held by 110 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| Deka DAXplus Maximum Dividend UCITS ETFEL4X | 4.49% | 0.30% | €252.82M |
| Amundi MDAX ESG UCITS ETFC007 | 4.19% | 0.30% | €182.49M |
| Xtrackers MDAX ESG Screened UCITS ETF 1DXDGM | 4.05% | 0.40% | €74.55M |
Show 5 more
| Invesco MDAX UCITS ETFDEAM | 3.48% | 0.19% | €626.66M |
| iShares STOXX Europe 600 Automobiles & Parts UCITS ETF (DE)EXV5 | 3.07% | 0.46% | €162.45M |
| Amundi F.A.Z. 100 UCITS ETFC006 | 0.92% | 0.15% | €103.2M |
| Amundi Global Luxury UCITS ETF EUR AccGLUX | 0.77% | 0.35% | €411.57M |
| iShares MSCI Europe Consumer Discretionary Sector UCITS ETFESIC | 0.66% | 0.18% | €113.79M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 11 Nov 2026 ($1 = €0.8987)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 29 Oct 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.